Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.8K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.9K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.9K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

328
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
328

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Response to Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

Pharmacotherapy·2026
Same author

Comment on "Rise of the Machines: Comparing Performance of Artificial Intelligence Large Language Models on Pharmacy Specialty Certification Examination Practice Questions".

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Don't stop the heart: a performance analysis of large language models and potassium dosing.

medRxiv : the preprint server for health sciences·2026
Same author

Toward the Future: A Race-Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug Dosing.

Clinical pharmacology and therapeutics·2026
Same author

Beyond Identifier Matching: An Empirical Characterization of Failure Modes in Biomedical Knowledge Graph Integration.

medRxiv : the preprint server for health sciences·2026
Same author

Incidence and Outcomes of Refractory Septic Shock per Consensus Clinical Criteria: A Multicohort Retrospective Study.

Critical care medicine·2026
Same journal

Predicting Chemotherapy Response from Staging Laparoscopy Images.

medRxiv : the preprint server for health sciences·2026
Same journal

Development and External Validation of a Machine Learning Model for 10-Year Ischemic Stroke Risk Prediction in Diverse Populations.

medRxiv : the preprint server for health sciences·2026
Same journal

MCH-Guard: Multimodal Machine Learning Framework for Risk Stratification of Cerebral Microhemorrhage Risk in the Alzheimer's Disease Neuroimaging Initiative.

medRxiv : the preprint server for health sciences·2026
Same journal

Genetic and maternal environmental contributions to estimated fetal weight at 20 weeks gestation compared with birthweight.

medRxiv : the preprint server for health sciences·2026
Same journal

Better immediate declarative memory is associated with forgetting during locomotor adaptation in chronic stroke and in older adults.

medRxiv : the preprint server for health sciences·2026
Same journal

An empirical Bayes framework for burden and dispersion association tests helps prioritize rare variants associated with Alzheimer's disease.

medRxiv : the preprint server for health sciences·2026
查看所有相关文章

相关实验视频

Updated: Jan 13, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.0K

使用大型语言模型识别药物相互作用.

Kaitlin Blotske1, Xingmeng Zhao1, Kelli Henry1

  • 1University of Colorado School of Medicine, Department of Biomedical Informatics.

medRxiv : the preprint server for health sciences
|January 8, 2026
PubMed
概括
此摘要是机器生成的。

大型语言模型 (LLM) 显示了识别药物相互作用 (DDI) 的潜力,但性能因任务复杂性而异. 随着推理的增加,可靠性下降,需要对药物安全性进行仔细评估.

关键词:
人工智能的人工智能是人工智能.医疗保健 医疗保健 医疗保健 医疗保健大型语言模型药物 药物 药物 药物药房 药房 药房 药房

更多相关视频

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K

相关实验视频

Last Updated: Jan 13, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K

科学领域:

  • 药理学和毒理学 药理学和毒理学
  • 人工智能在医学中的应用
  • 临床信息学 临床信息学

背景情况:

  • 药物相互作用 (DDI) 是患者损害的主要原因,特别是多种药物.
  • 目前的电子健康记录 (EHR) 系统使用基于规则的软件来检测DDI.
  • 大型语言模型 (LLM) 为DDI识别提供了潜力,但需要严格的验证.

研究的目的:

  • 为了比较LLM在识别和管理DDI方面的表现.
  • 开发和使用临床医生注释的数据集来评估LLM DDI检测能力.
  • 评估跨各种任务复杂性和相互作用严重性的LLM绩效.

主要方法:

  • 在750场景的DDI数据集上评估了三个LLM (GPT-4o-mini,MedGemma-27B,LLaMA3-70B).
  • 使用了三种任务格式:两种药物分类,三种药物歧视和4-6种药物选择.
  • 使用精度,回忆,F1得分,准确性,自我一致性和与信心一致的指标来评估性能.

主要成果:

  • LLaMA3-70B在两种药物分类召回和F1得分方面表现出色.
  • GPT-4o-mini在多种药物任务中表现出卓越的准确性和一致性.
  • 随着任务复杂度的增加,模型的自我一致性和可靠性下降.

结论:

  • 在复杂的任务中,LLM显示了DDI识别的可变能力,而复杂任务的性能下降.
  • 当前的LLM在不同的推理格式中缺乏统一的可靠性.
  • 多格式评估和可靠性意识评估对于安全的药物安全LLM应用至关重要.